Northwest Florida Clinical Research Group — Gulf Breeze, Florida

Northwest Florida Clinical Research Group is a clinical research site located in Gulf Breeze, Florida, United States 32561.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Northwest Florida Clinical Research Group has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome.

Sponsors: Longboard Pharmaceuticals, Xenon Pharmaceuticals Inc., Eisai Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northwest Florida Clinical Research Group?

Northwest Florida Clinical Research Group has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northwest Florida Clinical Research Group conducted?

Northwest Florida Clinical Research Group has 6 clinical trials on record, with 1 currently active. Their work covers Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome.

Is Northwest Florida Clinical Research Group accredited by Crixeo Health?

Yes — Northwest Florida Clinical Research Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Northwest Florida Clinical Research Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.